UNSPSC 51332515: Azaperone for veterinary use

This classification denotes an antipsychotic agent with the molecular formula C19H22FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19BV78AK7W, chemically known as 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)- but more generally known as azaperone, which bears US NIH Compound Identifier 15443. Azaperone most often comes in base and dimaleate forms. European Medicines Agency schedules Azaperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05636MIG.

UNSPSC 51332515 Azaperone for veterinary use is a Commodity code, but the recent state and local opportunities tagged under it show no activity related to azaperone or veterinary pharmaceuticals. Instead, the three most recent solicitations center on human pharmaceutical procurement—naloxone acquisition, direct-to-manufacturer prescription program design, and generic multi-source pharmaceutical distribution through a multistate cooperative purchasing vehicle. The code tag appears to be a misclassification in the sourcing system rather than a reflection of actual buying activity under this commodity. State and local governments are not currently soliciting azaperone for veterinary use through tracked procurement channels.

The mismatch between the code's nominal scope and the posted opportunities—which address emergency overdose response (Seminole County, Florida naloxone purchase), pharmacy benefit program restructuring (Texas HHS Commission RFI), and multistate generic pharmaceutical contracting (MMCAP RFP covering Minnesota and Oregon)—indicates that this Commodity code receives little to no relevant recent procurement activity. Pursue other UNSPSC codes aligned with human pharmaceutical or overdose-response-equipment procurement if your firm targets state and local health and human services contracts.